trapidil has been researched along with Angor Pectoris in 8 studies
Trapidil: A coronary vasodilator agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Overall results of this study show that both drugs are equally effective and safe for the short-term treatment of patients with chronic stable angina pectoris and that trapidil can be considered as therapeutically equivalent to ISDN." | 9.12 | Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study. ( Lehmacher, W; Meinertz, T, 2006) |
| "A large-scale study was conducted to assess the effect of long-term administration of trapidil on the prognosis of patients with angiographic evidence of coronary artery disease (CAD)." | 9.10 | Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]). ( Hirayama, A; Hosoda, S; Kawai, C; Kodama, K; Nonogi, H; Origasa, H; Sumiyoshi, T; Yui, Y, 2003) |
| "This study was undertaken to compare the antianginal efficacy of trapidil with that of isosorbide dinitrate (ISDN) in patients with stable angina pectoris." | 9.08 | Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris. ( Bussmann, WD; Raubach, KH; Vlahov, V; Wolter, K, 1997) |
| "Adenosine and related compounds have been shown to produce atrioventricular (AV) conduction block during acute myocardial ischemia." | 7.78 | Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia. ( Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I, 2012) |
| "Overall results of this study show that both drugs are equally effective and safe for the short-term treatment of patients with chronic stable angina pectoris and that trapidil can be considered as therapeutically equivalent to ISDN." | 5.12 | Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study. ( Lehmacher, W; Meinertz, T, 2006) |
| "A large-scale study was conducted to assess the effect of long-term administration of trapidil on the prognosis of patients with angiographic evidence of coronary artery disease (CAD)." | 5.10 | Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]). ( Hirayama, A; Hosoda, S; Kawai, C; Kodama, K; Nonogi, H; Origasa, H; Sumiyoshi, T; Yui, Y, 2003) |
| "This study was undertaken to compare the antianginal efficacy of trapidil with that of isosorbide dinitrate (ISDN) in patients with stable angina pectoris." | 5.08 | Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris. ( Bussmann, WD; Raubach, KH; Vlahov, V; Wolter, K, 1997) |
| "Adenosine and related compounds have been shown to produce atrioventricular (AV) conduction block during acute myocardial ischemia." | 3.78 | Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia. ( Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I, 2012) |
| " In a dosage of 300 mg a day orally trapymin had no clear influence on the non-esterified fatty acids." | 1.25 | [Influence of coronary-effective substances on the concentration of nonesterified fatty acids in the serum of patients with angina pectoris]. ( Heiland, G; Modersohn, D; Pankau, H; Urbaszek, W, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, I | 1 |
| Okumura, Y | 1 |
| Nagashima, K | 1 |
| Kofune, M | 1 |
| Ohkubo, K | 1 |
| Mano, H | 1 |
| Sonoda, K | 1 |
| Kasamaki, Y | 1 |
| Hirayama, A | 2 |
| Kodama, K | 1 |
| Yui, Y | 1 |
| Nonogi, H | 1 |
| Sumiyoshi, T | 1 |
| Origasa, H | 1 |
| Hosoda, S | 1 |
| Kawai, C | 1 |
| Meinertz, T | 1 |
| Lehmacher, W | 1 |
| Lohr, E | 1 |
| Raubach, KH | 1 |
| Vlahov, V | 1 |
| Wolter, K | 1 |
| Bussmann, WD | 1 |
| Urbaszek, W | 1 |
| Heiland, G | 1 |
| Pankau, H | 1 |
| Modersohn, D | 1 |
| Mentz, P | 1 |
| Pawelsky, KE | 1 |
| Giessler, C | 1 |
| Mest, HJ | 2 |
| Thomas, E | 1 |
3 trials available for trapidil and Angor Pectoris
| Article | Year |
|---|---|
Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]).
Topics: Angina Pectoris; Coronary Artery Disease; Death; Female; Follow-Up Studies; Heart Failure; Hospitali | 2003 |
Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Double-Blind Method; Exercise Test; E | 2006 |
Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Double-Blind Method; Drug Tolerance; Electroc | 1997 |
5 other studies available for trapidil and Angor Pectoris
| Article | Year |
|---|---|
Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia.
Topics: Adenosine; Angina Pectoris; Animals; Atrioventricular Block; Atrioventricular Node; Bundle of His; D | 2012 |
[Therapy of ischemic heart disease with Trapidil. Observations with 4,014 patients in medical practice].
Topics: Angina Pectoris; Coronary Disease; Drug Approval; Follow-Up Studies; Germany; Humans; Trapidil; Trea | 1994 |
[Influence of coronary-effective substances on the concentration of nonesterified fatty acids in the serum of patients with angina pectoris].
Topics: Angina Pectoris; Animals; Dipyridamole; Drug Combinations; Fatty Acids, Nonesterified; Humans; Oxyfe | 1975 |
[Thromboxane A2 antagonistic effect of antiangina drugs, with special reference to trapidil and trapidil derivatives].
Topics: Anesthesia; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiovascular Agents; | 1987 |
[Is there a renaissance for trapidil?].
Topics: Angina Pectoris; Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Human | 1986 |